| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/10/2011 | WO2010115078A3 Method of treating cognitive impairment |
| 03/10/2011 | WO2010108657A3 C5a binding nucleic acids and the use thereof |
| 03/10/2011 | WO2010093727A8 Quinazolinones as prolyl hydroxylase inhibitors |
| 03/10/2011 | US20110061114 Novel pro258 gene disruptions, and methods relating thereto |
| 03/10/2011 | US20110060037 Use of npy y5 receptor antagonists for the prevention of psycho-stimulant and opioid abuse |
| 03/10/2011 | US20110060035 Preventing and treating amyloid-beta deposition by stimulation of innate immunity |
| 03/10/2011 | US20110060025 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor |
| 03/10/2011 | US20110060024 Modulators of ATP-Binding Cassette Transporters |
| 03/10/2011 | US20110060017 Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 03/10/2011 | US20110060015 5-[5-[2-(3,5-BIS(Trifluoromethyl)Phenyl)-2-MethylpropanoMethylpropanoylmethylamino]-4-(4-Fluoro-2-Methylphenyl)]-2-Pyridinyl-2-Alkyl-Prolinamide As NK1 Receptor Antagonists |
| 03/10/2011 | US20110060014 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
| 03/10/2011 | US20110060012 4-[3-(aryloxy)benzylidene]-3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors |
| 03/10/2011 | US20110060010 Salts of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)piperidine-2,6-dione and derivatives thereof, or polymorphs of salts, process for preparing same and use thereof |
| 03/10/2011 | US20110060009 Hydroxamate-Based Inhibitors of Deacetylases |
| 03/10/2011 | US20110060008 Pharmaceutical composition containing acetylcholine esterase inhibitor and method for the preparation thereof |
| 03/10/2011 | US20110060007 Novel NIP Thiazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydroge-Nase-1 |
| 03/10/2011 | US20110060006 Functionally Selective Alpha2C Adrenoreceptor Agonists |
| 03/10/2011 | US20110060005 Treatment of mitochondrial disorders using a farnesyl transferase inhibitor |
| 03/10/2011 | US20110059999 Hydroxymethylcyclohexylamines |
| 03/10/2011 | US20110059998 Kit, composition, product or medicament for treating cognitive impairment |
| 03/10/2011 | US20110059997 SUBSTITUTED CYCLOALCANO[e AND d] PYRAZOLO [1,5-a]PYRIMIDINES/ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS AND METHODS FOR PRODUCTION AND THE USE THEREOF |
| 03/10/2011 | US20110059994 Composition for preventing or treating brain cancers |
| 03/10/2011 | US20110059993 1-(1-(2-Ethoxyethyl)-3-Ethyl-7-(4-Methylpyridin-2-Ylamino)-1H-Pyrazolo[4,3-D]Pyrimidin-5-YL) Piperidine-4-Carboxylic Acid And Salts Thereof |
| 03/10/2011 | US20110059992 New Compounds |
| 03/10/2011 | US20110059984 Heterocycles useful as modulators of ion channels |
| 03/10/2011 | US20110059982 Azaindole compounds for treatment of central nervous system disorders |
| 03/10/2011 | US20110059970 4-phenyl-1,3-thiazoles and 4-phenyl-1,3-oxazoles derivatives as cannabinoid receptor ligands |
| 03/10/2011 | US20110059968 Carboxamide compounds and their use as calpain inhibitors |
| 03/10/2011 | US20110059966 Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders |
| 03/10/2011 | US20110059965 Bicyclic derivatives as modulators of ion channels |
| 03/10/2011 | US20110059964 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 03/10/2011 | US20110059963 Compounds and methods for kinase modulation, and indications therefor |
| 03/10/2011 | US20110059959 Novel multicyclic compounds and the use thereof |
| 03/10/2011 | US20110059957 Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
| 03/10/2011 | US20110059955 Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof |
| 03/10/2011 | US20110059954 Cgrp antagonists |
| 03/10/2011 | US20110059947 Alpha 7 nicotinic agonists and antipsychotics |
| 03/10/2011 | US20110059940 2-Aryl Glycinamide Derivatives |
| 03/10/2011 | US20110059937 Il-8 receptor antagonists |
| 03/10/2011 | US20110059935 Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS |
| 03/10/2011 | US20110059932 Liver x receptor agonists |
| 03/10/2011 | US20110059923 Novel phosphate or a pharmaceutically acceptable salt thereof, a production method therefor and a pharmaceutical composition for preventing and treating central nervous system disorders containing the same as an active component |
| 03/10/2011 | US20110059920 Agent for regeneration and/or protection of nerves |
| 03/10/2011 | US20110059916 Methods and Compositions for Inducing Torpor in a Subject |
| 03/10/2011 | US20110059915 Purine derivatives and methods of use thereof |
| 03/10/2011 | US20110059912 Combination therapy comprising sglt inhibitors and dpp4 inhibitors |
| 03/10/2011 | US20110059909 Methods for treating inflammatory disorders |
| 03/10/2011 | US20110059905 Methods of treating disease-induced ataxia and non-ataxic imbalance |
| 03/10/2011 | US20110059896 Use of furin convertase inhibitors in the treatment of fibrosis and scarring |
| 03/10/2011 | US20110059891 Alpha-msh therapies for treatment of autoimmune disease |
| 03/10/2011 | US20110059888 Metastin derivatives and use thereof |
| 03/10/2011 | US20110059885 Treatment of diseases and conditions mediated by eicosanoids |
| 03/10/2011 | US20110059184 Medicament for treating parkinson's disease |
| 03/10/2011 | US20110059174 PKCdelta REGULATES NEUROINFLAMMATORY EVENTS |
| 03/10/2011 | US20110059172 Therapeutic compositions |
| 03/10/2011 | US20110059169 Method and Composition for Administering an NMDA Receptor Antagonist to a Subject |
| 03/10/2011 | US20110059167 Encapsulation of biologically active agents |
| 03/10/2011 | US20110059159 Nanoscale bound bilayers, methods of use and production |
| 03/10/2011 | US20110059148 Flexible Drug Delivery Chip, its Fabrication Method and Uses Thereof |
| 03/10/2011 | US20110059147 Long term drug delivery devices with polyurethane based polymers and their manufacture |
| 03/10/2011 | US20110059142 Encapsulation of biologically active agents |
| 03/10/2011 | US20110059141 Percutaneous absorption preparations of antidementia drugs |
| 03/10/2011 | US20110059118 Inhibitors of jak |
| 03/10/2011 | US20110059117 Liquid Compositions Capable of Foaming and Including Active Agents, and Methods for Making or Developing Same |
| 03/10/2011 | US20110059110 Antibody (11c7) anti nogo-a and its pharmaceutical use |
| 03/10/2011 | US20110059093 Use of an anti-tau ps422 antibody for the treatment of brain diseases |
| 03/10/2011 | US20110059092 Antibodies specific of the beta-amyloid peptides and their uses as diagnostic agents or drugs |
| 03/10/2011 | US20110059087 Il-17 and il-23 antagonists and methods of using the same |
| 03/10/2011 | US20110059083 Agent for treating disease |
| 03/10/2011 | US20110059055 Treating myelin diseases with optimized cell preparations |
| 03/10/2011 | US20110059019 Novel aryl piperazine derivatives useful as modulators of dopamine and serotonin receptors |
| 03/10/2011 | US20110059010 Dual phase drug release system |
| 03/10/2011 | US20110056863 Adhesive preparation containing donepezil, and package of the same |
| 03/10/2011 | DE10354893B4 Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen Use of deoxypeganine for the treatment of schizophrenic psychoses |
| 03/10/2011 | DE102009040870A1 Composition, useful for treating and prophylaxis of affective disorders including depression, migraine, headache and insomnia, comprises colloidal silver, gold and/or platinum and beta-aminoindole derivative |
| 03/10/2011 | DE102009039546A1 Neue therapeutische Konzepte für die Behandlung von Fibromyalgien New therapeutic approaches for the treatment of fibromyalgia |
| 03/10/2011 | CA2773083A1 Immunity-inducing agent |
| 03/10/2011 | CA2773038A1 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 03/10/2011 | CA2773035A1 Compounds for treating disorders or diseases associated with neurokinin 2 receptor activity |
| 03/10/2011 | CA2772980A1 Neuroprotective ganglioside compositions for use in treating or diagnosing huntington's disease |
| 03/10/2011 | CA2772931A1 Compositions and methods for treatment of neuropathic pain |
| 03/10/2011 | CA2772878A1 Ganglioside transmucosal formulations |
| 03/10/2011 | CA2772625A1 Compounds as tyrosine kinase modulators |
| 03/10/2011 | CA2772354A1 Method of treating compulsive disorders with alpha-2b adrenergic receptor agonists |
| 03/10/2011 | CA2772328A1 Novel forms of a multicyclic compound |
| 03/10/2011 | CA2772218A1 Methods of treating mitochondrial disorders using metalloporphyrins |
| 03/10/2011 | CA2772191A1 Method of treatment of neurodegenerative or neuro-muscular degenerative diseases and therapeutic agent to treat the same |
| 03/10/2011 | CA2772080A1 Synthesis of a neurostimulative piperazine |
| 03/10/2011 | CA2771770A1 Pcsk9 vaccine |
| 03/10/2011 | CA2771592A1 Substituted heterocyclic derivatives for the treatment of pain and epilepsy |
| 03/10/2011 | CA2771472A1 Oxopiperazine derivatives for the treatment of pain and epilepsy |
| 03/10/2011 | CA2771097A1 Therapeutic aryl-amido-aryl compounds and their use |
| 03/10/2011 | CA2771061A1 Chromone derivatives, a process for their preparation and their therapeutic applications |
| 03/09/2011 | EP2292771A2 Sense mRNA therapy |
| 03/09/2011 | EP2292770A2 Methods and means for producing proteins with predetermined post-translational modifications |
| 03/09/2011 | EP2292735A1 Cell fractions containing cells capable of differentiating into neural cells |
| 03/09/2011 | EP2292652A2 Interferons uses and compositions related thereto |
| 03/09/2011 | EP2292624A1 Process for the purification of olanzapine |
| 03/09/2011 | EP2292622A1 New crystalline form of a triazolo(4,5-d)pyrimidine compound |
| 03/09/2011 | EP2292614A1 Substituted pyrimidines as aurora kinase inhibitors |